Xenetic Biosciences (XBIO) Misses Q1 EPS by 13c

Xenetic Biosciences (NASDAQ: XBIO) reported Q1 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21).

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02